The medicines scheduling
delegate has confirmed the
interim decision recommended
by the TGA’s Advisory Committee
on Medicines Scheduling that
ranitidine (Zantac) be exempted
from Schedule 2 when in divided
preparations for oral use containing
300mg or less of ranitidine per
dosage unit, in the manufacturer’s
original pack containing not more
than seven dosage units.
The delegate has also confirmed
that esomeprazole (Nexium) will be
included in Appendix H.
The implementation date for the
changes is 01 Oct 2015.The above article was sent to subscribers in Pharmacy Daily's issue from 24 Jul 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Jul 15
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.